The Glimpse Group Enters Into A Follow-On 3D Anatomy Training Agreement With A Global Pharmaceutical Company

NYSE - LSE

RYCEF	1.04%	21.06	$
RBGPF	-3.92%	68.65	$
CMSD	-0.43%	21.09	$
CMSC	-0.56%	21.24	$
BCC	-2.2%	80.18	$
RIO	-0.54%	96.69	$
JRI	-0.32%	12.44	$
BP	1.29%	43.41	$
NGG	1.05%	82.15	$
BTI	1.15%	56.38	$
BCE	0.04%	23.36	$
AZN	2%	160.1	$
VOD	-0.43%	16.13	$
GSK	1.7%	51.15	$
RELX	2.75%	34.51	$

The Glimpse Group Enters Into A Follow-On 3D Anatomy Training Agreement With A Global Pharmaceutical Company

TECHNOLOGY 25.02.2026

NEW YORK, NY / ACCESS Newswire / February 25, 2026 / The Glimpse Group, Inc. ("Glimpse") (NASDAQ:GGRP), a diversified Immersive Technology platform company providing enterprise-focused Immersive Technology, Spatial Computing and Artificial Intelligence ("AI") driven software and services, announced today that its subsidiary company Sector 5 Digital ("S5D") entered into a mid 6-figure dollar follow-on contract with a global pharmaceutical company for a 3D based anatomy training platform.

Text size:

About The Glimpse Group, Inc.

The Glimpse Group (NASDAQ: GGRP) is a diversified Immersive technology platform company, providing enterprise-focused Immersive Technology, Spatial Computing and AI driven software & services. Glimpse's unique business model builds scale and a robust ecosystem, while simultaneously providing investors an opportunity to invest directly into this emerging industry via a diversified platform. For more information on The Glimpse Group, please visit www.theglimpsegroup.com

Safe Harbor Statement

This press release is being made pursuant to, and in accordance with, Rule 135 under the Securities Act of 1933, as amended (the "Securities Act"), and shall not constitute an offer to sell, or the solicitation of an offer to buy, any securities. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act and other applicable securities laws. This press release may contain certain forward-looking statements based on our current expectations, forecasts and assumptions that involve risks and uncertainties. Forward-looking statements, if provided, are based on information available to the Company as of the date hereof. Our actual results may differ materially from those stated or implied in such forward-looking statements, due to risks and uncertainties associated with our business. Forward-looking statements, if provided, include statements regarding our expectations, beliefs, intentions, or strategies regarding the future and can be identified by forward-looking words such as "anticipate," "believe," "view," "could," "estimate," "expect," "intend," "may," "should," and "would" or similar words. All forecasts, if provided, are based on information available at this time and management expects that internal projections and expectations may change over time. In addition, any forecasts, if provided, are entirely on management's best estimate of our future financial performance given our current contracts, current backlog of opportunities and conversations with new and existing customers about our products and services. We assume no obligation to update the information included in this press release, whether as a result of new information, future events or otherwise.

Company Contact:

Maydan Rothblum
CFO & COO
The Glimpse Group, Inc.
(917) 292-2685
[email protected]

SOURCE: The Glimpse Group, Inc.

View the original press release on ACCESS Newswire

M.Robinson--AT

Arizona Tribune - The Glimpse Group Enters Into A Follow-On 3D Anatomy Training Agreement With A Global Pharmaceutical Company

The Glimpse Group Enters Into A Follow-On 3D Anatomy Training Agreement With A Global Pharmaceutical Company

Featured

NASA images reveal crater left by SpaceX rocket's Moon crash

ISS hosts first spacewalk by a Frenchwoman

China's Baidu, betting on AI, posts fifth straight quarterly revenue drop

Elderly far more at risk from rising heat than thought: study